Clinical Trial Update: Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells [Phase 1]

View source ↗

Summary

Status update on a Phase 1 clinical study evaluating adoptive treatment with allogeneic gamma-delta T cells for multi-drug resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multi-drug Resistant Tuberculosis

Drugs mentioned

• Allogeneic gamma-delta T cell therapy (gamma-delta T cells)

Snippet

Sponsor: Zhinan Yin, Ph.D. | Conditions: Multi-drug Resistant Tuberculosis | Phase 1 | Status: UNKNOWN